Changing Paradigms in T-Cell Lymphomas 2010
3 December, 2010
Orlando FL , USA
Overview and Purpose:
The Changing Paradigms in T-Cell Lymphomas satellite symposium is designed to provide community oncologists who treat patients with T-cell lymphomas with practical, multidisciplinary approaches that can be applied immediately to their clinical practice. This program will include expert commentary outlining the essentials of T-cell lymphoma histopathology and the most current therapeutic approaches to both peripheral and cutaneous T-cell lymphomas. Tumor board sessions will provide an opportunity to reinforce best practices in diagnosis and treatment and provide an insight into how experts manage cases when clinical data are lacking. Debate and audience questions and comments will add to the interactive nature of this program.
Target Audience:
This educational program is directed toward medical oncologists and hematologists interested in the treatment of patients with T-cell lymphoid malignancies. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of T-cell lymphomas are also invited to attend.
Learning Objectives:
At the conclusion of this symposium, you should be able to:
Discuss the histopathologic features of the various PTCL and CTCL lymphoma entities
Evaluate current treatment options and strategies for adverse events in patients with PTCL and CTCL
Appraise the efficacy and safety of emerging treatment strategies for patients with CTCL and PTCL
Evaluate the role of new combinations and new agents in the continuum of care for patients with T-cell lymphomas
The Changing Paradigms in T-Cell Lymphomas satellite symposium is designed to provide community oncologists who treat patients with T-cell lymphomas with practical, multidisciplinary approaches that can be applied immediately to their clinical practice. This program will include expert commentary outlining the essentials of T-cell lymphoma histopathology and the most current therapeutic approaches to both peripheral and cutaneous T-cell lymphomas. Tumor board sessions will provide an opportunity to reinforce best practices in diagnosis and treatment and provide an insight into how experts manage cases when clinical data are lacking. Debate and audience questions and comments will add to the interactive nature of this program.
Target Audience:
This educational program is directed toward medical oncologists and hematologists interested in the treatment of patients with T-cell lymphoid malignancies. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of T-cell lymphomas are also invited to attend.
Learning Objectives:
At the conclusion of this symposium, you should be able to:
Discuss the histopathologic features of the various PTCL and CTCL lymphoma entities
Evaluate current treatment options and strategies for adverse events in patients with PTCL and CTCL
Appraise the efficacy and safety of emerging treatment strategies for patients with CTCL and PTCL
Evaluate the role of new combinations and new agents in the continuum of care for patients with T-cell lymphomas
Venue
Location: Rosen Centre Hotel
In a city known as a world-class destination, Orlando Florida, this award-winning Orlando hotel establishes a spectacular standard of meeting quality. Exceptional facilities, a highly respected staff..
+14079969840
Related events
Changing Paradigms in T-Cell Lymphomas 3 December, 2010
